Candida auris Invasive Infections during a COVID-19 Case Surge-Reference-Cited by-同舟云学术

Candida auris Invasive Infections during a COVID-19 Case Surge

Published:2021-09-17 Issue:10 Volume:65 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Hanson Blake M.¹²³^ORCID,Dinh An Q.²³,Tran Truc T.²³,Arenas Sebastian⁴,Pronty Darryl⁴,Gershengorn Hayley B.⁴⁵⁶,Ferreira Tanira⁴⁵,Arias Cesar A.¹²³,Shukla Bhavarth S.⁴⁷^ORCID

Affiliation:

1. Center for Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA

2. Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, Houston, Texas, USA

3. Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, Houston, Texas, USA

4. University of Miami Health System, Miami, Florida, USA

5. Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA

6. Department of Medicine, Division of Critical Care, Albert Einstein College of Medicine, Bronx, New York, USA

7. Division of Infectious Diseases, Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA

Abstract

Clinical cases of C. auris noted during a COVID-19 surge led to an epidemiological, clinical, and genomic investigation. Evaluation identified a close genetic relationship but inconclusive epidemiologic link between all cases. Prolonged hospitalization due to critical illness from COVID-19 and use of antimicrobials may have contributed to clinical infections.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

University of Texas Health Science Center at Houston

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01146-21

Reference8 articles.

1. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study

2. CDC. 2019. Antibiotic resistance threats in the United States. U.S. Department of Health and Human Services Atlanta GA. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Accessed 20 February 2021.

3. Candida auris: a Review of the Literature

4. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

5. IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated With Poor Clinical and Microbiologic Outcomes in Candida auris Bloodstream Infection: A Multicenter Retrospective Cohort Study;Clinical Infectious Diseases;2024-08-13

2. Epidemiology of Invasive Candidiasis;Clinical Epidemiology;2024-08

3. Fluphenazine is Effective Against Candida auris Infection;Proceedings of the National Academy of Sciences, India Section B: Biological Sciences;2024-06-13

4. The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in England;Journal of Medical Microbiology;2024-05-21

5. The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at Hospitals;Infection and Drug Resistance;2024-04